Date: 2018-01-10

Type of information: Nomination

Compound: vice-president

Company: Ipsen (France)

Therapeutic area: Cancer - Oncology - Rare diseases - Neurological diseases

Type agreement: nomination

Action mechanism:



  • • On January  10, 2018, Ipsen announced the appointment of Dr Aidan Murphy as executive vice-president, technical operations, effective 1st January 2018. Dr. Murphy now reports directly to David Meek, CEO of Ipsen, and serves on the executive leadership Team.  Since joining Ipsen in 2007 Dr. Murphy has held a number of manufacturing leadership roles in many countries. Since 2014 he  has held the position of senior vice president biologics development and manufacturing at Ipsen. Also during his tenure at Ipsen, he has led the manufacturing sites of Tianjin (China),Dublin (Ireland), and Wrexham (UK) and occupied global roles as SVP CMC (Chemistry, Manufacturing, and Controls) Development & Engineering and Head of Specialty Care Manufacturing. He holds a PhD in organic chemistry from Trinity College, Dublin. Dr Murphy succeeds Jonathan Barnsley as EVP Technical Operations following Mr Barnsley’s retirement at the end of 2017.

Financial terms:

Latest news:

Is general: Yes